106 related articles for article (PubMed ID: 8851203)
1. [The clinical significance of the measurement of serum soluble interleukin-2 receptors in various diseases].
Sugimoto H; Hashimoto N; Suzuki S; Gejyo F
Rinsho Byori; 1996 Feb; 44(2):176-82. PubMed ID: 8851203
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Dejica D
Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
[TBL] [Abstract][Full Text] [Related]
3. Increased serum soluble interleukin 2 receptor levels in patients with viral liver diseases.
Yamaguchi S; Onji M; Ohta Y
Hepatogastroenterology; 1988 Oct; 35(5):245-8. PubMed ID: 3068111
[TBL] [Abstract][Full Text] [Related]
4. [The significance of soluble IL-2 receptors in rheumatoid arthritis with interstitial pneumonia].
Tada S; Namba J; Yokota S; Sugimoto K; Imajo K; Kawabata H; Irie S; Kimura I; Kitani H; Tanizaki K
Arerugi; 1992 Mar; 41(3):428-33. PubMed ID: 1575640
[TBL] [Abstract][Full Text] [Related]
5. [The significance of sIL-2R detection in various hepatic diseases].
Xuan SY; Jiang LM; Lu WH
Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Apr; 18(2):92-4. PubMed ID: 9812507
[TBL] [Abstract][Full Text] [Related]
6. Study of interleukin-2 receptor in schistosomiasis mansoni and its analogous changes in collagen diseases and schistosomal arthropathy.
Khalil HM; el Missiry AG; Fahmy HM; Khalil NM; Nadia ; Sabry M; Abdel Atty HE; Tamara FA; Amer N; el Baz HG
J Egypt Soc Parasitol; 1995 Aug; 25(2):289-302. PubMed ID: 7665927
[TBL] [Abstract][Full Text] [Related]
7. [Soluble IL-2 receptor levels in rheumatic diseases].
Takaya M; Ichikawa Y; Shimizu H; Uchiyama M; Moriuchi J; Arimori S
Ryumachi; 1993 Jun; 33(3):229-34. PubMed ID: 8346465
[TBL] [Abstract][Full Text] [Related]
8. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus.
Pettersson T; Söderblom T; Nyberg P; Riska H; Linko L; Klockars M
J Rheumatol; 1994 Oct; 21(10):1820-4. PubMed ID: 7837144
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
[TBL] [Abstract][Full Text] [Related]
10. [The serum level of soluble interleukin-2 receptors in patients with rheumatoid arthritis].
Medvedev AN; Korshunov NI; Nasonov EL; Baranov AA; Shilkina NP
Ter Arkh; 1996; 68(5):24-7. PubMed ID: 9082592
[TBL] [Abstract][Full Text] [Related]
11. Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis.
Dejica D; Treichel U; Pár A; Chira O; Meyer zum Büschenfelde KH
Z Gastroenterol; 1997 Jan; 35(1):15-21. PubMed ID: 9123953
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of soluble interleukin-2 receptor in multiple myeloma].
Akimoto Y; Ishiyama T; Ueno H; Hino K; Tomoyasu S; Tsuruoka N
Rinsho Ketsueki; 1995 Nov; 36(11):1247-51. PubMed ID: 8691563
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
[TBL] [Abstract][Full Text] [Related]
14. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
[TBL] [Abstract][Full Text] [Related]
15. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status.
Zerler B
Cancer Cells; 1991 Dec; 3(12):471-9. PubMed ID: 1820093
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
[TBL] [Abstract][Full Text] [Related]
17. [Soluble interleukin 2 receptor (sIL-2R) in chronic polyarthritis].
Herzog C; Herzog A; Aeschlimann A; Gerber H; Müller W
Z Rheumatol; 1990; 49(1):8-10. PubMed ID: 2327181
[TBL] [Abstract][Full Text] [Related]
18. [Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes].
Horák P; Hermanová Z; Ordeltová M; Faltýnek L; Kusá L; Budíková M; Vavrdová V; Opíchalová D; Ciferská H; Scudla V
Vnitr Lek; 2004 Jun; 50(6):422-7. PubMed ID: 15346634
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
Kitaoka S; Shiota G; Kawasaki H
Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
Grüngreiff K; Reinhold D; Ansorge S
Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]